Prohibits an insurer from imposing a requirement of prior authorization for any admission, item, service, treatment, test, exam, study, procedure or any generic or brand name prescription drug ordered by a primary care provider
Prohibits credit reporting, executions, attachments against a principal residence for judgments based on medical debt. Defines medical debt as an amount for the receipt of health care services, products, or devices.
Grants the director of the department of health the authority to approve or deny any applications for professional licensure pending before certain boards of licensure that have been unable to establish a quorum for 30 business days.
Requires the secretary of the executive office of health and human services to monitor and mandate changes to the price-setting practices of pharmacy benefit managers to prohibit the spread pricing payment model.